45Indexed trials
canonical disease area
Neuro-Oncology
Intelligence
Neuro-Oncology intelligence: 45 indexed trials, 12 recruiting studies, 41 sponsors across 34 countries.
12Recruiting
41Sponsors
34Countries
Leading sponsors
NeuroVita Clinic20 recruiting
Assistance Publique - Hôpitaux de Paris21 recruiting
University of Texas Southwestern Medical Center20 recruiting
Annick Desjardins20 recruiting
Hospices Civils de Lyon11 recruiting
Costas Hadjipanayis11 recruiting
Cortice Biosciences, Inc.10 recruiting
Eli Lilly and Company10 recruiting
Assiut University10 recruiting
Hoffmann-La Roche11 recruiting
Duke University10 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Geographic activity
United States24trials
Germany8trials
France7trials
Netherlands5trials
Austria5trials
Canada3trials
Spain3trials
Switzerland3trials
Italy3trials
Israel3trials
China2trials
Poland2trials
Leading interventions
Bevacizumab3trials
Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes2trials
Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes2trials
Temozolomide2trials
ACT0011trials
APG1011trials
5-ALA1trials
Active follow-up1trials
7 Tesla Scanning1trials
Adjuvant chemotherapy as normal based on standard clinical protocols determined by the neuro-oncologist1trials
Alectinib1trials
Abemaciclib1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.